Medicine
Ajovy 225 mg/1.5 mL injection
Ajovy 225 mg/1.5 mL injection is a prescription medicine containing Fremanezumab for subcutaneous use, marketed by Teva Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original outer carton…
Key facts
- Active ingredient (INN)
- Fremanezumab
- Brand
- Ajovy
- Strength
- 225 mg/1.5 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 container of 1.5 mL, 3 containers of 1.5 mL, 1 syringe of 1.5 mL
- Marketing authorisation holder
- Teva Pharmaceuticals
- Manufacturer
- Teva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original outer carton to protect from light. After removal from the refrigerator, AJOVY must be used within 7 days or discarded. Once stored at room temperature, do not place back in the refrigerator. Do not freeze. If necessary, AJOVY may be kept in the original carton at room temperature up to 30°C (86°F) for a maximum of 7 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CD03 Fremanezumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 September 2018
- Identifiers
- RxCUI 2056695, 2056700, 2287903 +1DailyMed set ID 98e344ea-5916-4947-b6f2-4a76ccc04b6bNDC 51759-204, 51759-202Application BLA761089
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 container in 1 carton / 1.5 mL in 1 container | 51759-202-10 | Teva Pharmaceuticals | 29 March 2020 |
| 3 container in 1 carton / 1.5 mL in 1 container | 51759-202-22 | Teva Pharmaceuticals | 31 August 2020 |
| 1 syringe, glass in 1 carton / 1.5 mL in 1 syringe, glass | 51759-204-10 | Teva Pharmaceuticals | 15 September 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Fremanezumab is a prescription medicine indicated for the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients, among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Fremanezumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FremanezumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AJOVY prescribing information (Teva Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Ajovy: European public assessment report (EPAR) · European Medicines Agency
Need Ajovy 225 mg/1.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.